Diminished tumorigenic phenotype after depletion of mitochondrial DNA

Cell Growth and Differentiation

Volumn 8, Issue 11, 1997, Pages 1189-1198

  Cavalli, Luciane R ^a,b   Varella Garcia, Marileila ^a   Liang, Bertrand C ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Univ Federal de Parana Auritiba   (Brazil)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYTOTOXIC AGENT; ETHIDIUM BROMIDE; MITOCHONDRIAL DNA;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL MEMBRANE RESISTANCE; CHROMOSOME ABERRATION; CONTROLLED STUDY; ETIOLOGY; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASMS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0030728737     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Richter, C., Schweizer, M., Cossarizza, A., and Franceschi, C. Control of apoptosis by the cellular ATP level. FEBS Lett., 378: 107-110, 1996.
2. Shay, J. W. Cytoplasmic modification of nuclear gene expression. Mol. Cell Biochem., 57: 17-26, 1983.
3. Israel, B. A., and Schaeffer, W. I. Cytoplasmic suppression of malignancy. In Vitro Cell. Dev. Biol., 23: 627-632, 1987.
4. Israel, B. A., and Schaeffer, W. I. Cytoplasmic mediation of malignancy. In Vitro Cell. Dev. Biol., 24: 487-490, 1988.
5. Hayashi, J-I., Takemitsu, M., and Nonaka, I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somatic Cell Mol. Genet., 18: 123-129, 1992.
6. Wilkie, D., and Evans, I. Mitochondria and the yeast cell surface: implications for carcinogenesis. Trends Biochem. Sci., 7: 147-151, 1982.
7. Soslau, G., Fuhrer, J. P., Nass, M. M. K., and Warren, L. The effects of ethidium bromide on the membrane glycopeptides in control and virus-transformed cells. J. Biol. Chem., 249: 3014-3020, 1974.
8. Zinkewich-Peotti, K., Parent, M., and Morais, R. Mitochondrial DNA modulation of the anchorage-independent phenotype of transformed avian cells. Cancer Res., 50: 6675-6682, 1990.
9. Zinkewich-Peotti, K., Parent, M., and Morais, R. On the tumorigenicity of mitochondrial DNA-depleted avian cells. Cancer Lett., 59: 119-124, 1991.
10. Morais, R., Zinkewich-Peotti, K., Parent, M., Wang, H., Babai, F., and Zollinger, M. Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res., 54: 3889-3896, 1994.
11. Baggetto, L. G. Role of mitochondria in carcinogenesis. Eur. J. Cancer, 29A: 156-159, 1993.
12. Liang, B. C., and Hays, L. Mitochondrial DNA copy number changes in human gliomas. Cancer Lett., 105: 167-173, 1996.
13. Liang, B. C. Direct isolation of variably amplified cDNAs from human tumor cell lines. Int. J. Oncol., 7: 611-615, 1995.
14. Liang, B. C. Evidence of mitochondrial DNA insertion in human low grade glial tumors. Mutat. Res., 354: 27-33, 1996.
15. Kruse, C., Mitchell, D. H., Kleinschmidt-DeMasters, B. K., Franklin, W. A., Morse, H. G., Spector, E. B., and Lillehei, K. O. Characterization of a continuous human glioma cell line DBTRG-O5MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell Dev. Biol., 28A: 609-614, 1992.
16. Engel, L. W., and Young, N. H. Human breast carcinoma in continuous culture: a review. Cancer Res., 38: 4327-4339, 1978.
17. King, M. P., and Attardi, G. Isolation of human cell lines lacking mitochondrial DNA. Methods in Enzymology: Mitochondrial Biogenesis and Genetics, Vol. 264, pp. 304-313. New York: Academic Press, Inc., 1996.
18. Richter, C., Schweizer, M., Cossarizza, A., and Franceschi, C. Control of apoptosis by the cellular ATP level. FEBS Lett., 378: 107-110, 1996.
19. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. BCL-2 heterodimerizes in vivo with a conserved homolog, BAX, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
20. Greenhalf, W., Stephan, C., and Chaudhuri, B. Role of mitochondria and C-terminal membrane anchor of BCL-2 in BAX induced growth arrest and mortality in Saccharomyces cerevisiae. FEBS Lett., 380: 169-175, 1996.
21. Liang, B. C. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J. Neuro-oncol., 29: 149-155, 1996.
22. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T-I., Jones, D. P., and Wang, X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science (Washington DC), 275: 1129-1132, 1997.
23. Kluck, R. M., Bossy-Wetzed, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science (Washington DC), 275: 1132-1136, 1997.
24. Zinkewich-Peotti, K., Parent, M., and Morais, R. Mitochondrial DNA modulation of the anchorage-independent phenotype of transformed avian cells. Cancer Res., 50: 6675-6682, 1990.
25. Morais, R., Zinkewich-Peotti, M., Parent, M., Wang, H., Babai, F., and Zollinger, M. Tumor-forming ability in athymic nude mice of human cell lines devoid of Mitochondrial DNA. Cancer Res., 54: 3889-3896, 1994.
26. Zinkewich-Peotti, K., Parent, M., and Morais, R. On the tumorigenicity of mitochondrial DNA-depleted avian cells. Cancer Lett., 59: 119-124, 1991.
27. Hayashi, J., Takemitsu, M., and Nonaka, I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somatic Cell Mol. Genet., 18: 123-129, 1992.
28. Hickman, J. A. Apoptosis and chemotherapy resistance. Eur. J. Cancer, 6: 921-926, 1996.
29. Susin, S. A., Zamzani, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. BCL-2 inhibits the mitochondria release of an apoptotic protease. J. Exp. Med., 184: 1331-1341, 1996.
30. Nikiforov, M. A., Hagen, K., Ossovskaya, V. S., Connor, T. M. F., Lowe, S. W., Deichman, G. I., and Gudkov, A. V. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene, 13: 1709-1719, 1996.
31. Bianchi, M. S., Bianchi, N. O., and Bailliet, G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet. Cell Genet., 71: 99-103, 1995.
32. Boultwood, J., Fidler, C., Mills, K. I., Frodsham, P. M., Kusec, R., Gaiger, A., Gale, R. E., Linch, D. C., Littlewood, T. J., Moss, P. A. H., and Wainscoat, J. S. Amplification of mitochondrial DNA in acute myeloid leukaemia. Br. J. Hematol., 95: 426-431, 1996.
33. Pederson, P. L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res., 22: 198-274, 1978.
34. He, C., Masson, J. Y., and Ramotar, D. Functional mitochondria are essential for Saccharomyces cerevisiae cellular resistance to bleomycin. Curr. Genet., 30: 279-283, 1996.
35. Jia, L., Kelsey, S. M., Grahn, M. F., Jiang, X. R., and Newland, A. C. Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood, 87: 2401-2410, 1996.
36. Burger, A. M., Kaur, G., Alley, M. C., Supko, J. G., Malspeis, L., Grever, M. R., and Sausville, E. A. Tyrphostin AG17, [(3,5-di-tert-butyl-4-hydroxybenzylidene)-malononitrile], inhibits cell growth by disrupting mitochondria. Cancer Res., 55: 2794-2799, 1995.
37. Andrews, P. A., and Albright, K. D. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res., 52: 1895-1901, 1992.
38. 2: evidence for mitochondrial involvement. Cancer Res., 54: 1497-1502, 1994.
39. Dorward, A. M., and Singh, G. Energetic characteristics of cisplatin resistant ovarian carcinoma cells. Anticancer Res., 16: 443-448, 1996.
40. Liang, B. C., Ross, D. A., Greenberg, H. S., Metzler, P. S., and Trent, J. M. Evidence of allelic imbalance of chromosome 6 in glial neoplasms. Neurology, 17: 91-96, 1994.
41. Liang, B. C., Ross, D. A., and Reed, E. Genomic DNA copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J. Neuro-oncol., 26: 17-23, 1995.
42. Zhang, H., Zhang, R., and Liang, P. Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res., 24: 2454-2455, 1996.
43. Schwartz, L. M., Milligan, C. E., Bielke, W., and Robinson, S. J. Cloning cell death genes. In: L. M. Schwartz and B. A. Osborne (eds.), Cell Death, Chapter 7, I-V, pp. 107-138. New York: Academic Press, 1995.
44. Chomyn, A. Platelet mediated transformation of human mitochondrial DNA-less cells. Methods in Enzymology: Mitochondrial Biogenesis and Genetics, Vol. 264, pp. 334-339. New York: Academic Press, 1996.
45. Kimmelman, A. C., Ross, D. A., and Liang, B. C. Loss of heterozygosity of chromosome 10p in human gliomas. Genomics, 34: 250-254, 1996.